K4 Elite
K4 Elite
Thymogen is a synthetic dipeptide of glutamic acid and tryptophan, developed in the former USSR and studied as an immunomodulatory agent in experimental and clinical-report settings.
Thymogen is a synthetic dipeptide composed of glutamic acid and tryptophan (commonly written Glu-Trp, with the gamma-glutamyl isomer described in much of the source literature). It was derived from research on thymic immunomodulatory peptides and developed in the former Soviet Union as a low-molecular-weight immunocorrector.
As one of the smallest peptides studied for immunomodulatory activity, Thymogen has attracted interest as a structurally simple model for how short peptides can influence immune-cell populations. Much of the primary literature is published in Russian-language journals and describes experimental and clinical-report use in that context.
Its low molecular weight and simple structure make it a frequent subject in peptide-immunomodulation research, where investigators compare it to larger thymic peptides such as thymulin and thymosin fractions.
Published reports describe Thymogen influencing indices of cellular and humoral immunity, with proposed effects on T-lymphocyte differentiation and on the balance of immune-cell subpopulations. Investigators have suggested the dipeptide acts on regulatory signaling in immune tissues, though the precise molecular targets remain less fully characterized than those of larger, well-studied peptides.
Some experimental work associates the glutamyl-tryptophan motif with modulation of cytokine and antioxidant pathways in cell and animal models, effects researchers describe as consistent with a broad immunoregulatory rather than a directly antimicrobial role.
Russian-language experimental and clinical-report literature (reviewed in English in peptide-immunomodulation surveys such as Khavinson and colleagues) describes Thymogen being evaluated for effects on immune indices in models of secondary immunodeficiency, reporting changes in lymphocyte subpopulations relative to controls in the studies cited.
Comparative peptide-immunomodulation reviews describe the glutamyl-tryptophan dipeptide alongside other short thymic-derived peptides, summarizing experimental datasets in which the compound altered proliferation or differentiation markers of immune cells in vitro. These reports characterize laboratory exposures and are not human-use recommendations.
Combinations examined in the research literature. Descriptive only — not a recommendation to combine compounds.
References are being compiled for this entry.